Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2006-04-18
2006-04-18
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S204100, C424S207100, C424S208100, C424S209100, C424S211100, C424S225100, C424S226100, C424S227100, C424S228100, C424S229100, C424S230100, C424S231100, C424S234100, C424S249100, C424S253100, C424S258100, C424S263100, C424S268100, C424S273100, C424S277100
Reexamination Certificate
active
07029678
ABSTRACT:
The present invention provides vaccine compositions comprising an oil-in-water emulsion optionally with 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccine compositions are potent induces of a range of immune responses.
REFERENCES:
patent: 4912094 (1990-03-01), Myers et al.
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5554372 (1996-09-01), Hunter
patent: 5585103 (1996-12-01), Raychaudhuri et al.
patent: 5650155 (1997-07-01), Cornelius et al.
patent: 5667784 (1997-09-01), Cornelius et al.
patent: 5709879 (1998-01-01), Barchfeld et al.
patent: 5723130 (1998-03-01), Hancock et al.
patent: 6146632 (2000-11-01), Momin et al.
patent: 6270769 (2001-08-01), Raychaudhuri et al.
patent: 6299884 (2001-10-01), Van Nest et al.
patent: 6372227 (2002-04-01), Garcon et al.
patent: 6451325 (2002-09-01), Van Nest et al.
patent: 6620414 (2003-09-01), Garcon-Johnson et al.
patent: 6623739 (2003-09-01), Momin et al.
patent: 6893644 (2005-05-01), Garcon-Johnson et al.
patent: 2003/0095974 (2003-05-01), Garcon et al.
patent: 0 382 271 (1990-08-01), None
patent: 0 399 843 (1990-11-01), None
patent: WO 88/09336 (1988-12-01), None
patent: WO 92/16556 (1992-10-01), None
patent: WO 94/00153 (1994-01-01), None
patent: WO 94/21292 (1994-03-01), None
patent: WO 94/27636 (1994-12-01), None
patent: WO 95/17209 (1995-06-01), None
patent: WO 99/11241 (1999-03-01), None
Wang et al (World Journal of Gastroenterology vol. 10, No. 15, Aug. 1, 2004, pp 2157-2162).
Hilleman (PNAS USA vol. 101 Suppl 2, pp 14560-14566, Oct. 5, 2004)□□.
Tramont et al (Expert Opinion on Emerging Drugs, vol. 8, No. 1, pp 37-45, May 2003).
Haynes,Science, 260: 1279-1286 (1993).
Johnston, et al.,Science, 260: 1286-1293 (1993).
Mester, et al.,Review of Infectious Diseases, 13: 5935-5945 (1991).
McElrath, et al.,PNAS USA, 93: 3972-3977 (1996).
Krause, et al.,Infectious Disease Clinics of North America, 13(1): 61-81 (1999).
Pardoll,Current Opin. in Immunol., 4(5): 619-623 (1992).
Garcon Nathalie Marie-Josephe
Momin Patricia Marie
Conger Michael M.
Navarro Mark
SmithKline Beecham Biologicals (S.A.)
LandOfFree
Vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3525250